Azenta Return on Tangible Equity 2010-2025 | AZTA

Current and historical return on tangible equity values for Azenta (AZTA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Azenta Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-06-30 $-0.11B $0.86B -12.16%
2025-03-31 $-0.07B $0.91B -6.76%
2024-12-31 $-0.16B $0.93B -15.38%
2024-09-30 $-0.17B $0.95B -14.23%
2024-06-30 $-0.16B $1.06B -12.22%
2024-03-31 $-0.15B $1.27B -10.59%
2023-12-31 $-0.02B $1.35B -1.22%
2023-09-30 $-0.01B $1.46B -0.84%
2023-06-30 $-0.04B $1.62B -1.94%
2023-03-31 $-0.05B $1.78B -2.08%
2022-12-31 $2.08B $1.78B 82.44%
2022-09-30 $2.13B $2.67B 94.55%
2022-06-30 $2.18B $2.80B 123.97%
2022-03-31 $2.22B $2.83B 188.55%
2021-12-31 $0.13B $0.72B 21.04%
2021-09-30 $0.11B $0.67B 19.88%
2021-06-30 $0.12B $0.50B 22.35%
2021-03-31 $0.09B $0.54B 18.08%
2020-12-31 $0.08B $0.52B 16.07%
2020-09-30 $0.07B $0.55B 14.06%
2020-06-30 $0.45B $0.45B 105.41%
2020-03-31 $0.44B $0.43B 142.60%
2019-12-31 $0.44B $0.43B 223.94%
2019-09-30 $0.44B $0.40B 560.77%
2019-06-30 $0.03B $-0.02B 49.64%
2019-03-31 $0.05B $-0.03B 32.57%
2018-12-31 $0.11B $-0.04B 47.16%
2018-09-30 $0.12B $0.36B 36.97%
2018-06-30 $0.12B $0.33B 40.66%
2018-03-31 $0.12B $0.32B 39.36%
2017-12-31 $0.06B $0.25B 22.26%
2017-09-30 $0.06B $0.32B 21.36%
2017-06-30 $0.06B $0.30B 20.11%
2017-03-31 $0.05B $0.28B 18.03%
2016-12-31 $-0.05B $0.26B -19.42%
2016-09-30 $-0.07B $0.27B -25.18%
2016-06-30 $-0.07B $0.26B -22.79%
2016-03-31 $-0.07B $0.25B -19.97%
2015-12-31 $0.01B $0.33B 3.08%
2015-09-30 $0.02B $0.46B 3.31%
2015-06-30 $0.01B $0.46B 1.75%
2015-03-31 $0.02B $0.45B 5.17%
2014-12-31 $0.02B $0.45B 5.09%
2014-09-30 $0.03B $0.47B 6.35%
2014-06-30 $0.04B $0.48B 7.62%
2014-03-31 $0.01B $0.48B 3.02%
2013-12-31 $0.01B $0.45B 2.19%
2013-09-30 $0.00B $0.48B -0.44%
2013-06-30 $0.11B $0.45B 23.08%
2013-03-31 $0.11B $0.45B 25.04%
2012-12-31 $0.13B $0.46B 28.36%
2012-09-30 $0.14B $0.52B 32.46%
2012-06-30 $0.03B $0.40B 8.73%
2012-03-31 $0.09B $0.39B 23.06%
2011-12-31 $0.11B $0.38B 27.33%
2011-09-30 $0.13B $0.39B 32.81%
2011-06-30 $0.14B $0.45B 37.25%
2011-03-31 $0.09B $0.39B 26.84%
2010-12-31 $0.09B $0.36B 27.19%
2010-09-30 $0.06B $0.33B 20.55%
2010-06-30 $0.02B $0.30B 7.67%
2010-03-31 $-0.02B $0.28B -8.26%
2009-12-31 $-0.20B $0.26B -72.53%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.400B $0.656B
Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $43.991B 53.84
Tempus AI (TEM) United States $13.179B 0.00
Doximity (DOCS) United States $12.725B 56.62
Hims & Hers Health (HIMS) United States $9.572B 78.43
IRhythm Technologies (IRTC) United States $5.461B 0.00
Hinge Health (HNGE) United States $4.399B 0.00
Privia Health (PRVA) United States $2.828B 209.46
Inspire Medical Systems (INSP) United States $2.771B 40.74
Heartflow (HTFL) $2.557B 0.00
Phreesia (PHR) United States $1.884B 0.00
Enovis (ENOV) United States $1.766B 9.34
10x Genomics (TXG) United States $1.744B 0.00
Omnicell (OMCL) United States $1.497B 28.84
Schrodinger (SDGR) United States $1.436B 0.00
Clover Health Investments (CLOV) United States $1.343B 0.00
Claritev (CTEV) United States $1.135B 0.00
Evolent Health (EVH) United States $1.134B 0.00
Fulgent Genetics (FLGT) United States $0.679B 0.00
Zepp Health (ZEPP) Netherlands $0.652B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.481B 0.00
Talkspace (TALK) United States $0.445B 133.00
Butterfly Network (BFLY) United States $0.405B 0.00
Carlsmed (CARL) United States $0.354B 0.00
TruBridge (TBRG) United States $0.300B 52.53
Outset Medical (OM) United States $0.247B 0.00
Health Catalyst (HCAT) United States $0.239B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.234B 0.00
Nyxoah SA (NYXH) Belgium $0.213B 0.00
KORU Medical Systems (KRMD) United States $0.195B 0.00
CapsoVision (CV) United States $0.175B 0.00
MDxHealth SA (MDXH) Belgium $0.168B 0.00
CareCloud (CCLD) United States $0.163B 7.38
American Well (AMWL) United States $0.111B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.109B 0.00
EUDA Health Holdings (EUDA) Singapore $0.077B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
Pulmonx (LUNG) United States $0.070B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
111 (YI) China $0.056B 0.00
HeartBeam (BEAT) United States $0.046B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Precipio (PRPO) United States $0.025B 0.00
PROFUSA (PFSA) United States $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Movano (MOVE) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00